Cytokine pattern in cystic fibrosis patients during antibiotic therapy and gene therapy using adenoviral vector

European Cytokine Network

Volumn 13, Issue 3, 2002, Pages 324-330

  Reix, Philippe ^a   Bellon, Gabriel ^a   Bienvenu, Jacques ^a   Pavirani, Andrea ^a   Levrey Hadden, Hélène ^a  

^a HÔPITAL DEBROUSSE   (France)

Author keywords

Adenoviral vector; Antibiotic; Cystic fibrosis; Cytokine

Indexed keywords

ADENOVIRUS VECTOR; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CEFTAZIDIME; COMPLEMENTARY DNA; CYTOKINE; GENTAMICIN; IMIPENEM; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 8; PRISTINAMYCIN; TIMENTIN; TOBRAMYCIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CYSTIC FIBROSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; HUMAN; IMMUNE RESPONSE; LUNG LAVAGE; RESPIRATORY TRACT INFECTION; VIRAL GENE THERAPY;

ADENOVIRIDAE; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; COMBINED MODALITY THERAPY; CYSTIC FIBROSIS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENETIC VECTORS; HUMANS;

ADENOVIRIDAE; BACTERIA (MICROORGANISMS);

EID: 0036634267     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations
2. Cystic fibrosis
3. Gene therapy in cystic fibrosis
4. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis
5. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis
6. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis
7. Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: A phase I clinical trial
8. Virus treatment questioned after gene therapy death
9. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA
10. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Toxicity study
11. Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates
12. Role of early region 3 (E3) in pathogenesis of adenovirus disease
13. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia
14. Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses
15. Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class 1 restriction in response to adenovirus vectors delivered to mouse liver
16. Cytokine production by cultured human bronchial epithelial cells infected with a replication-deficient adenoviral gene transfer vector or wild-type adenovirus type 5
17. Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-alpha and respiratory syncytial virus stimulation
18. Nasal cytokine production in viral acute upper respiratory infection of childhood
19. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense
20. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration
21. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis
22. Lower airway inflammation in infants and young children with cystic fibrosis
23. Inflammation and infection in naive human cystic fibrosis airway grafts
24. Circulating immunoreactive interleukin-6 in cystic fibrosis
25. Plasma tumour necrosis factor alpha in cystic fibrosis
26. Inflammatory markers in cystic fibrosis
27. Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease
28. Cystic fibrosis: Inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa
29. Genistein inhibits constitutive and inducible NFkappaB activation and decreases IL-8 production by human cystic fibrosis bronchial gland cells
30. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway
31. Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs
32. Aerosol-mediated delivery of recombinant adenovirus to the airways of nonhuman primates